A Phase II, Open Label Study Evaluating an Alternative Schedule of Velcade/Dexamethasone Plus Doxil in the Treatment of Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2012
At a glance
- Drugs Bortezomib; Dexamethasone; Doxorubicin liposomal
- Indications Multiple myeloma
- Focus Adverse reactions
- 05 Apr 2012 Actual patient number changed from 33 to 32 as reported by ClinicalTrials.gov.
- 18 Aug 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 20 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.